Sections include: emerging biology of GM-CSF, autoimmune pulmonary alveolar proteinosis (aPAP), infection, wound healing, and enhanced anti-cancer potential yet mitigation of immune checkpoint inhibitor immune-related adverse events. This evidence concerns the gene CSF2 and cancer.